Aileron Therapeutics Inc.
(ALRN)
undefined
undefined%
At close: undefined
2.25
-1.32%
After-hours Dec 13, 2024, 05:42 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | - | - | - | - | - | - | - | - | - | - | 22.35M |
Cost of Revenue | 119.00K | 169.00K | 121.00K | 163.00K | 155.00K | 218.00K | 95.00K | 232.00K | 325.00K | 9.33M | 12.23M |
Gross Profit | -119.00K | -169.00K | -121.00K | -163.00K | -155.00K | -218.00K | -95.00K | -232.00K | -325.00K | -9.33M | 10.12M |
Operating Income | -16.28M | -27.65M | -26.61M | -20.50M | -29.96M | -31.90M | -23.01M | -18.17M | -12.89M | -16.03M | 3.28M |
Interest Income | - | - | - | - | 587.00K | 355.00K | 404.00K | 46.00K | 13.00K | 10.00K | 6.00K |
Pretax Income | -15.73M | -27.33M | -26.20M | -21.16M | -29.37M | -31.55M | -22.60M | -18.12M | -12.88M | -16.02M | 3.29M |
Net Income | -15.73M | -27.01M | -25.76M | -21.82M | -28.78M | -31.55M | -22.60M | -18.12M | -12.88M | -16.07M | 194.00K |
Selling & General & Admin | 11.36M | 9.68M | 9.60M | 9.33M | 12.29M | 13.45M | 8.77M | 7.89M | 5.06M | 6.70M | 6.84M |
Research & Development | 3.99M | 17.97M | 17.01M | 11.17M | 17.66M | 18.45M | 14.24M | 10.28M | 7.83M | 9.33M | 12.23M |
Other Expenses | 928.00K | 318.00K | 441.00K | -800.00K | - | - | - | -18.17M | - | - | - |
Operating Expenses | 16.28M | 27.65M | 26.61M | 20.50M | 29.96M | 31.90M | 23.01M | 18.17M | 12.89M | 6.70M | 6.84M |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 16.28M | 27.65M | 26.61M | 20.50M | 29.96M | 31.90M | 23.01M | 18.17M | 12.89M | 16.03M | 19.07M |
Income Tax | - | -318.00K | -441.00K | 661.00K | -587.00K | 355.00K | 34.00K | - | - | 43.00K | 3.10M |
Shares Outstanding (Basic) | 4.60M | 4.54M | 4.44M | 1.74M | 1.23M | 736.91K | 372.15K | 545.72K | 545.72K | 19.00K | 19.00K |
Shares Outstanding (Diluted) | 4.60M | 4.54M | 4.44M | 1.74M | 1.23M | 736.91K | 372.15K | 545.72K | 545.72K | 19.02K | 17.89K |
EPS (Basic) | -3.42 | -5.95 | -5.8 | -12.52 | -23.46 | -42.81 | -60.74 | -33.21 | -23.6 | -845.63 | 10.21 |
EPS (Diluted) | -3.42 | -5.95 | -5.8 | -12.52 | -23.46 | -42.81 | -60.74 | -33.21 | -23.6 | -844.96 | 10.85 |
EBITDA | -15.61M | -27.48M | -26.48M | -20.33M | -29.80M | -31.33M | -23.01M | -17.94M | -12.57M | -15.44M | 4.06M |
Depreciation & Amortization | 119.00K | 169.00K | 121.00K | 163.00K | 155.00K | 218.00K | 95.00K | 232.00K | 325.00K | 585.00K | 774.00K |